首页> 外文期刊>International journal of clinical pharmacology and therapeutics >Adverse non-drug-related complaints by healthy volunteers in Phase I studies compared to the healthy general population.
【24h】

Adverse non-drug-related complaints by healthy volunteers in Phase I studies compared to the healthy general population.

机译:与健康的普通人群相比,健康志愿者在第一阶段研究中出现的与药物无关的不良投诉。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: Some complaints that are reported as adverse drug reactions by healthy subjects during participation in Phase I studies are common complaints in healthy individuals from the normal population. The objective of this study was to compare the incidence of complaints in a group of 192 healthy volunteers in Phase I studies with a control group of 112 healthy subjects who matched the Phase I group participants in terms of demographic and socioeconomic characteristics, and to investigate the relationship between some psychological factors and the incidence of complaints. METHODS: Both groups completed a questionnaire on the incidence of complaints during the previous 2 - 4 weeks. Trait anxiety was assessed by the trait scale of the State-Trait Anxiety Inventory (STAI-T), depressive mood by the Beck's Depression Inventory-II (BDI-II) and perceived self-efficacy by the Self-Efficacy Scale (SES). RESULTS: Compared to the control group, Phase I volunteers presented a significantly lower incidence of stomach pain, back pain, limb or joint pain, headaches, fainting spells, palpitations, shortness of breath, constipation, loose stools or diarrhea, nausea, gas or indigestion, feeling nervous or anxious, feeling restless, getting tired very easily, muscle tension, aches, or soreness, and concentration difficulties. Significant positive correlations were found between the STAI-T and BDI-II scores and the incidence of several complaints; inversely, the SES score correlated negatively with several complaints. CONCLUSION: The incidence of complaints in healthy subjects is not of a random character and depends on psychological characteristics. Volunteers in Phase I studies are a self-selected sample with a lower tendency to report non-drug-related adverse events than their peers from the general population. The impact of this self-selection bias on the assessment of tolerability during Phase I studies deserves further evaluation.
机译:目的:一些被健康受试者报告为参与第一阶段研究的药物不良反应的投诉是正常人群中健康个体的常见投诉。这项研究的目的是比较第一阶段研究中的192名健康志愿者与对照组的112名健康受试者的投诉发生率,这些健康受试者在人群和社会经济特征方面与第一阶段的参与者相匹配,并调查一些心理因素与投诉发生率之间的关系。方法:两组均完成了有关前2-4周内投诉发生率的问卷调查。通过状态-特质焦虑量表(STAI-T)的特质量表,贝克氏抑郁量表-II(BDI-II)的抑郁情绪和自我效能感量表(SES)来评估特质焦虑。结果:与对照组相比,第一阶段志愿者的胃痛,背痛,四肢或关节痛,头痛,晕厥,心,呼吸急促,便秘,大便稀少或腹泻,恶心,气体或腹泻的发生率显着降低。消化不良,感到紧张或焦虑,不安,非常容易疲倦,肌肉紧张,疼痛或酸痛以及注意力不集中。在STAI-T和BDI-II得分与几起投诉的发生之间发现显着正相关。相反,SES得分与几个抱怨呈负相关。结论:健康受试者的抱怨发生率不是随机的,而是取决于心理特征。在第一阶段研究中,志愿者是自我选择的样本,与普通人群相比,他们报告非药物相关不良事件的可能性更低。在第一阶段研究中,这种自我选择偏见对耐受性评估的影响值得进一步评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号